Literature DB >> 34225786

Elevated NTCP expression by an iPSC-derived human hepatocyte maintenance medium enhances HBV infection in NTCP-reconstituted HepG2 cells.

Xinlei Li1, Zhaohui Xu1, Bidisha Mitra2, Minghang Wang1, Haitao Guo2, Zongdi Feng3,4.   

Abstract

BACKGROUND: The sodium taurocholate cotransporting polypeptide (NTCP) is a functional receptor for hepatitis B virus (HBV). NTCP-reconstituted human hepatoma cells support HBV infection, but the infection is suboptimal and no apparent HBV spread has been observed in this system.
RESULTS: We found that NTCP-reconstituted HepG2 cells were highly susceptible to HBV infection after cells were cultured in a commercial human inducible pluripotent stem cell (iPSC)-derived hepatocyte maintenance medium (HMM). The enhanced HBV infection coincided with increased NTCP expression, and was observed in six different clones of HepG2-NTCP cells. Promoter assays indicated that HMM activated the cytomegalovirus immediate-early (IE) promoter that drives the NTCP expression in the HepG2-NTCP cells. RNA-Seq analysis revealed that HMM upregulated multiple metabolic pathways. Despite highly upregulated NTCP expression by HMM, no obvious HBV spread was observed even in the presence of PEG 8000.
CONCLUSIONS: Our data suggest that this particular medium could be used to enhance HBV infection in NTCP-reconstituted hepatocytes in vitro.

Entities:  

Keywords:  CMV promoter; Entry; Hepatitis B virus; NTCP

Year:  2021        PMID: 34225786     DOI: 10.1186/s13578-021-00641-1

Source DB:  PubMed          Journal:  Cell Biosci        ISSN: 2045-3701            Impact factor:   7.133


  42 in total

Review 1.  Hepatitis B virus biology.

Authors:  C Seeger; W S Mason
Journal:  Microbiol Mol Biol Rev       Date:  2000-03       Impact factor: 11.056

Review 2.  HBV cccDNA: viral persistence reservoir and key obstacle for a cure of chronic hepatitis B.

Authors:  Michael Nassal
Journal:  Gut       Date:  2015-06-05       Impact factor: 23.059

Review 3.  Hepatitis B virus cccDNA: Formation, regulation and therapeutic potential.

Authors:  Yuchen Xia; Haitao Guo
Journal:  Antiviral Res       Date:  2020-05-22       Impact factor: 5.970

Review 4.  Hepatitis B virus infection.

Authors:  Man-Fung Yuen; Ding-Shinn Chen; Geoffrey M Dusheiko; Harry L A Janssen; Daryl T Y Lau; Stephen A Locarnini; Marion G Peters; Ching-Lung Lai
Journal:  Nat Rev Dis Primers       Date:  2018-06-07       Impact factor: 52.329

5.  A global scientific strategy to cure hepatitis B.

Authors:  Peter A Revill; Francis V Chisari; Joan M Block; Maura Dandri; Adam J Gehring; Haitao Guo; Jianming Hu; Anna Kramvis; Pietro Lampertico; Harry L A Janssen; Massimo Levrero; Wenhui Li; T Jake Liang; Seng-Gee Lim; Fengmin Lu; M Capucine Penicaud; John E Tavis; Robert Thimme; Fabien Zoulim
Journal:  Lancet Gastroenterol Hepatol       Date:  2019-04-10

6.  Three decades of hepatitis B control with vaccination.

Authors:  Liliane C Meireles; Rui Tato Marinho; Pierre Van Damme
Journal:  World J Hepatol       Date:  2015-08-28

Review 7.  Hepatitis B viruses: reverse transcription a different way.

Authors:  Michael Nassal
Journal:  Virus Res       Date:  2008-03-12       Impact factor: 3.303

8.  Hepatitis B cure: From discovery to regulatory approval.

Authors:  Anna S Lok; Fabien Zoulim; Geoffrey Dusheiko; Marc G Ghany
Journal:  Hepatology       Date:  2017-08-01       Impact factor: 17.425

9.  A research agenda for curing chronic hepatitis B virus infection.

Authors:  Harvey Alter; Timothy Block; Nathaniel Brown; Alan Brownstein; Carol Brosgart; Kyong-Mi Chang; Pei-Jer Chen; Francis V Chisari; Chari Cohen; Hashem El-Serag; Jordan Feld; Robert Gish; Jeffrey Glenn; Tim Greten; Haitao Guo; Ju-Tao Guo; Yujin Hoshida; Jianming Hu; Kris V Kowdley; Wenhui Li; Jake Liang; Stephan Locarnini; Anna S Lok; William Mason; Brian McMahon; Anand Mehta; Robert Perrillo; Peter Revill; Charles M Rice; JoAnn Rinaudo; Raymond Schinazi; Christoph Seeger; Kirty Shetty; John Tavis; Fabien Zoulim
Journal:  Hepatology       Date:  2018-01-24       Impact factor: 17.425

10.  Access to Treatment for Hepatitis B Virus Infection - Worldwide, 2016.

Authors:  Yvan Hutin; Muazzam Nasrullah; Philippa Easterbrook; Boniface Dongmo Nguimfack; Esteban Burrone; Francisco Averhoff; Marc Bulterys
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2018-07-20       Impact factor: 17.586

View more
  1 in total

1.  New and effective method to develop primary hepatocytes from liver cancer patients.

Authors:  Jia-Yan Li; Li-Li Wang; Jing Fan; Du-Xian Liu; Jian-Bo Han; Yu-Feng Zhang; Dan-Dan Yin; Yong-Xiang Yi
Journal:  Exp Biol Med (Maywood)       Date:  2022-04-26
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.